{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:18:56Z","timestamp":1789165136578,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>This study aimed to investigate the evolving data trends of the Chinese Haemovigilance Network (CHN) and provide insights into its future development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      Data were collected from the\n                      <jats:styled-content style=\"fixed-case\">CHN<\/jats:styled-content>\n                      covering the period of 2018\u20132023. The data were subdivided into three phases and analysed from several aspects. We also compared the percentage distribution of adverse transfusion reactions (\n                      <jats:styled-content style=\"fixed-case\">ATRs<\/jats:styled-content>\n                      ) between the\n                      <jats:styled-content style=\"fixed-case\">CHN<\/jats:styled-content>\n                      and other national haemovigilance reports.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, the number of hospitals participating in reporting ATRs has increased, from a total of 188 in 2018\u20132019 to 206 in 2020\u20132021 and 222 in 2022\u20132023. The CHN received 6410 ATRs cases: 1915 in 2018\u20132019, 2265 in 2020\u20132021 and 2230 in 2022\u20132023. The reports for all three phases covered 11 types of ATRs that involved transfusion of nine blood components. The highest percentage of ATRs was caused by apheresis platelets (591\/1915 in 2018\u20132019, 756\/2265 in 2020\u20132021 and 760\/2230 in 2022\u20132023). In terms of ATR severity, no severity was overwhelming (91.70% in 2018\u20132019, 95.74% in 2020\u20132021 and 93.34% in 2022\u20132023). The CHN report showed a higher proportion of allergic reactions compared to serious hazards of transfusion. Similarly, differences in the distribution of ATRs were also observed between the CHN system and both the Australian and transfusion and transplantation reactions in patients haemovigilance systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Over the past 6\u2009years, the CHN has established a relatively advanced haemovigilance system. Comparison of the CHN and other national haemovigilance reports revealed differences in the classification and percentage distribution of ATRs, underscoring the need for standardized reporting to enhance global transfusion safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/vox.70303","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:16:17Z","timestamp":1781745377000},"page":"1376-1384","source":"Crossref","is-referenced-by-count":0,"title":["Development and improvement of Chinese Haemovigilance Network from 2018 to 2023"],"prefix":"10.1111","volume":"121","author":[{"given":"Ling","family":"Li","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu  Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu  Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangqiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion The First Affiliated Hospital of Anhui Medical University  Hefei China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[{"name":"Wuhu Blood Center  Wuhu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu  Chengdu Sichuan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory The Sixth People's Hospital of Chengdu  Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"He","sequence":"additional","affiliation":[{"name":"Clinical Transfusion Research Center, Institute of Blood Transfusion Chinese Academy of Medical Sciences and Peking Union Medical College  Chengdu China"},{"name":"Key Laboratory of Transfusion Adverse Reactions CAMS  Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-7335","authenticated-orcid":false,"given":"Jue","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Transfusion Research Center, Institute of Blood Transfusion Chinese Academy of Medical Sciences and Peking Union Medical College  Chengdu China"},{"name":"Key Laboratory of Transfusion Adverse Reactions CAMS  Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8173-9656","authenticated-orcid":false,"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Transfusion Research Center, Institute of Blood Transfusion Chinese Academy of Medical Sciences and Peking Union Medical College  Chengdu China"},{"name":"Key Laboratory of Transfusion Adverse Reactions CAMS  Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12582"},{"key":"e_1_2_9_3_1","volume-title":"Global consultation on Haemovigilance, 20\u201322 November 2012: report","author":"World Health Organization","year":"2012"},{"key":"e_1_2_9_4_1","first-page":"EE05","article-title":"Haemovigilance: a current update in Indian perspective","volume":"10","author":"Mukherjee S","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12547"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05454.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15082"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2024.03.001"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13570"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2022.03.005"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13291"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574886318666221206114638"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2022.09.070"},{"key":"e_1_2_9_14_1","unstructured":"World Health Organization.Action framework to advance universal access to safe effective and quality\u2010assured blood products 2020\u20132023. Available from:https:\/\/www.who.int\/publications\/i\/item\/9789240000384. Last accessed 18 Dec 2025."},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2009.10.002"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16362"},{"key":"e_1_2_9_17_1","first-page":"405","article-title":"Blood safety policy: should cautionary policies be adopted with caution?","volume":"16","author":"Riva L","year":"2018","journal-title":"Blood Transfus"},{"key":"e_1_2_9_18_1","unstructured":"FunkMB HeidenM M\u00fcllerS.Haemovigilance Report of the Paul\u2010Ehrlich\u2010Institut 2020: Assessment of the Reports of Serious Adverse Transfusion Reactions pursuant to Section 63i AMG.2021. Available from:https:\/\/www.pei.de\/SharedDocs\/Downloads\/DE\/newsroom\/pflichtberichte\/haemovigilanzberichte\/haemovigilanz\u2010bericht\u20102020.pdf?__blob=publicationFile&v=4. Last accessed 18 Dec 2025."},{"key":"e_1_2_9_19_1","unstructured":"BellamyM NarayanS DaviesJ PolesD MilserE Carter\u2010GrahamS et al.The 2020 annual SHOT report.2021. Available from:https:\/\/www.shotuk.org\/wp-content\/uploads\/2020\/09\/Interactive_SHOT-REPORT-2020_V2.1.pdf. Last accessed 18 Dec 2025."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01313-6"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12918"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12833"},{"key":"e_1_2_9_23_1","unstructured":"Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee.Guidelines for the blood transfusion and tissue transplantation services in the UK. Available from:https:\/\/www.transfusionguidelines.org\/red-book\/chapter-7\/7-3. Last accessed 18 Dec 2025."}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.70303","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vox.70303","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.70303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:58:23Z","timestamp":1789163903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.70303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/vox.70303"],"URL":"https:\/\/doi.org\/10.1111\/vox.70303","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}